Mycoplasma Detection Service Market Report – Research, Industry Analysis Reports and Market Demands

Global Mycoplasma Detection Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

2 Company Profiles

3 Market Competition, by Players

3.1 Global Mycoplasma Detection Service Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Mycoplasma Detection Service by Company Revenue
- 3.2.2 Top 3 Mycoplasma Detection Service Players Market Share in 2025
- 3.2.3 Top 6 Mycoplasma Detection Service Players Market Share in 2025
3.3 Mycoplasma Detection Service Market: Overall Company Footprint Analysis
- 3.3.1 Mycoplasma Detection Service Market: Region Footprint
- 3.3.2 Mycoplasma Detection Service Market: Company Product Type Footprint
- 3.3.3 Mycoplasma Detection Service Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global Mycoplasma Detection Service Consumption Value and Market Share by Type (2021-2026)
4.2 Global Mycoplasma Detection Service Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

5.1 Global Mycoplasma Detection Service Consumption Value Market Share by Application (2021-2026)
5.2 Global Mycoplasma Detection Service Market Forecast by Application (2027-2032)

6 North America

6.1 North America Mycoplasma Detection Service Consumption Value by Type (2021-2032)
6.2 North America Mycoplasma Detection Service Market Size by Application (2021-2032)
6.3 North America Mycoplasma Detection Service Market Size by Country
- 6.3.1 North America Mycoplasma Detection Service Consumption Value by Country (2021-2032)
- 6.3.2 United States Mycoplasma Detection Service Market Size and Forecast (2021-2032)
- 6.3.3 Canada Mycoplasma Detection Service Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Mycoplasma Detection Service Market Size and Forecast (2021-2032)

7 Europe

7.1 Europe Mycoplasma Detection Service Consumption Value by Type (2021-2032)
7.2 Europe Mycoplasma Detection Service Consumption Value by Application (2021-2032)
7.3 Europe Mycoplasma Detection Service Market Size by Country
- 7.3.1 Europe Mycoplasma Detection Service Consumption Value by Country (2021-2032)
- 7.3.2 Germany Mycoplasma Detection Service Market Size and Forecast (2021-2032)
- 7.3.3 France Mycoplasma Detection Service Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Mycoplasma Detection Service Market Size and Forecast (2021-2032)
- 7.3.5 Russia Mycoplasma Detection Service Market Size and Forecast (2021-2032)
- 7.3.6 Italy Mycoplasma Detection Service Market Size and Forecast (2021-2032)

8 Asia-Pacific

8.1 Asia-Pacific Mycoplasma Detection Service Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Mycoplasma Detection Service Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Mycoplasma Detection Service Market Size by Region
- 8.3.1 Asia-Pacific Mycoplasma Detection Service Consumption Value by Region (2021-2032)
- 8.3.2 China Mycoplasma Detection Service Market Size and Forecast (2021-2032)
- 8.3.3 Japan Mycoplasma Detection Service Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Mycoplasma Detection Service Market Size and Forecast (2021-2032)
- 8.3.5 India Mycoplasma Detection Service Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Mycoplasma Detection Service Market Size and Forecast (2021-2032)
- 8.3.7 Australia Mycoplasma Detection Service Market Size and Forecast (2021-2032)

9 South America

9.1 South America Mycoplasma Detection Service Consumption Value by Type (2021-2032)
9.2 South America Mycoplasma Detection Service Consumption Value by Application (2021-2032)
9.3 South America Mycoplasma Detection Service Market Size by Country
- 9.3.1 South America Mycoplasma Detection Service Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Mycoplasma Detection Service Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Mycoplasma Detection Service Market Size and Forecast (2021-2032)

10 Middle East & Africa

10.1 Middle East & Africa Mycoplasma Detection Service Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Mycoplasma Detection Service Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Mycoplasma Detection Service Market Size by Country
- 10.3.1 Middle East & Africa Mycoplasma Detection Service Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Mycoplasma Detection Service Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Mycoplasma Detection Service Market Size and Forecast (2021-2032)
- 10.3.4 UAE Mycoplasma Detection Service Market Size and Forecast (2021-2032)

11 Market Dynamics

11.1 Mycoplasma Detection Service Market Drivers
11.2 Mycoplasma Detection Service Market Restraints
11.3 Mycoplasma Detection Service Trends Analysis
11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

12.1 Mycoplasma Detection Service Industry Chain
12.2 Mycoplasma Detection Service Upstream Analysis
12.3 Mycoplasma Detection Service Midstream Analysis
12.4 Mycoplasma Detection Service Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology
14.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Mycoplasma Detection Service market size was valued at US$ 691 million in 2025 and is forecast to a readjusted size of US$ 936 million by 2032 with a CAGR of 4.2% during review period.
Mycoplasma Detection Service refers to outsourced laboratory testing services used to detect mycoplasma contamination in cell cultures, biological products, cell therapy materials, vaccines, research samples, and biopharmaceutical production environments. These services commonly use PCR, qPCR, culture-based methods, DNA staining, enzymatic detection, or validated rapid microbiological methods to identify contamination. Service providers usually offer sample receipt, nucleic acid extraction, testing, quality control, result interpretation, certificate issuance, and technical consultation. The service helps laboratories and manufacturers ensure cell line purity, avoid experimental failure, meet regulatory expectations, and reduce contamination risk in biologics, gene therapy, vaccine, and life science research workflows.
The industrial chain of Mycoplasma Detection Service includes upstream resources such as sample collection tubes, PCR reagents, qPCR instruments, culture media, DNA staining reagents, extraction kits, positive controls, negative controls, sterile consumables, laboratory information systems, and quality management tools. The midstream consists of sample registration, pretreatment, assay selection, nucleic acid amplification, culture verification, data analysis, quality review, report generation, and compliance documentation. Downstream users mainly include biopharmaceutical companies, cell therapy developers, vaccine manufacturers, cell banks, CROs, CDMOs, academic laboratories, diagnostic research institutions, and quality control departments. Related services include method validation, contamination investigation, routine monitoring, rapid release testing, troubleshooting, and long-term testing program support.
The market for Mycoplasma Detection Service is growing rapidly as biopharmaceutical manufacturing, cell therapy, gene therapy, vaccine development, and cell culture-based research place greater emphasis on contamination control and quality compliance. A key trend is the shift from traditional culture-based testing toward rapid PCR and qPCR services that shorten turnaround time and support batch release decisions. Customers are also paying more attention to method validation, regulatory documentation, sample traceability, sensitivity, specificity, and laboratory accreditation. In the coming years, providers with strengths in rapid molecular testing, GMP-compliant workflows, global sample logistics, and biopharmaceutical quality support are expected to gain competitive advantages. Overall, the industry is moving toward faster, more standardized, and more compliance-driven mycoplasma testing services.
This report is a detailed and comprehensive analysis for global Mycoplasma Detection Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Mycoplasma Detection Service market size and forecasts, in consumption value ($ Million), 2021-2032
Global Mycoplasma Detection Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Mycoplasma Detection Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Mycoplasma Detection Service market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Mycoplasma Detection Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Mycoplasma Detection Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Charles River Laboratories International, Thermo Fisher Scientific, SGS, Bionique Testing Laboratories, WuXi AppTec, Labcorp, IDEXX BioAnalytics, WiCell, Creative Biogene, Eurofins Scientific, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Mycoplasma Detection Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Culture-based Mycoplasma Detection
PCR/qPCR Mycoplasma Detection
Others
Market segment by Service Purpose
Product Release Testing
Contamination Investigation Testing
Regulatory Compliance Testing
Others
Market segment by Sample Type
Cell Bank Testing
Cell Culture Testing
Others
Market segment by Application
Biopharmaceutical Companies
Contract Research/Manufacturing Organizations (CROs/CMOs)
Universities and Research Institutions
Others
Market segment by players, this report covers
Charles River Laboratories International
Thermo Fisher Scientific
SGS
Bionique Testing Laboratories
WuXi AppTec
Labcorp
IDEXX BioAnalytics
WiCell
Creative Biogene
Eurofins Scientific
Hylabs
JOINN Laboratories
Shimadzu Diagnostics
CellSafe
FullHope Biomedical
Syngene International
Beyotime
CTI Cert
Shenke Bio
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Mycoplasma Detection Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Mycoplasma Detection Service, with revenue, gross margin, and global market share of Mycoplasma Detection Service from 2021 to 2026.
Chapter 3, the Mycoplasma Detection Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Mycoplasma Detection Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Mycoplasma Detection Service.
Chapter 13, to describe Mycoplasma Detection Service research findings and conclusion.

Buy now